| Mutational heterogeneity in cancer and the search for new cancer-associated genes MS Lawrence, P Stojanov, P Polak, GV Kryukov, K Cibulskis, ... Nature 499 (7457), 214-218, 2013 | 6102 | 2013 |
| Evolution and impact of subclonal mutations in chronic lymphocytic leukemia DA Landau, SL Carter, P Stojanov, A McKenna, K Stevenson, ... Cell 152 (4), 714-726, 2013 | 1683 | 2013 |
| Mutations driving CLL and their evolution in progression and relapse DA Landau, E Tausch, AN Taylor-Weiner, C Stewart, JG Reiter, J Bahlo, ... Nature 526 (7574), 525-530, 2015 | 1234 | 2015 |
| Resistance to checkpoint blockade therapy through inactivation of antigen presentation M Sade-Feldman, YJ Jiao, JH Chen, MS Rooney, M Barzily-Rokni, ... Nature communications 8 (1), 1136, 2017 | 904 | 2017 |
| Genomic complexity of multiple myeloma and its clinical implications S Manier, KZ Salem, J Park, DA Landau, G Getz, IM Ghobrial Nature reviews Clinical oncology 14 (2), 100-113, 2017 | 633 | 2017 |
| Discovery of a periosteal stem cell mediating intramembranous bone formation S Debnath, AR Yallowitz, J McCormick, S Lalani, T Zhang, R Xu, NA Li, ... Nature 562 (7725), 133-139, 2018 | 569 | 2018 |
| Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia DA Landau, K Clement, MJ Ziller, P Boyle, J Fan, H Gu, K Stevenson, ... Cancer cell 26 (6), 813-825, 2014 | 403 | 2014 |
| Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition JA Burger, DA Landau, A Taylor-Weiner, I Bozic, H Zhang, K Sarosiek, ... Nature communications 7 (1), 11589, 2016 | 401 | 2016 |
| Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics AS Nam, R Chaligne, DA Landau Nature Reviews Genetics 22 (1), 3-18, 2021 | 349 | 2021 |
| Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring A Zviran, RC Schulman, M Shah, STK Hill, S Deochand, CC Khamnei, ... Nature medicine 26 (7), 1114-1124, 2020 | 320 | 2020 |
| Somatic mutations and cell identity linked by Genotyping of Transcriptomes AS Nam, KT Kim, R Chaligne, F Izzo, C Ang, J Taylor, RM Myers, ... Nature 571 (7765), 355-360, 2019 | 291 | 2019 |
| Epigenetic evolution and lineage histories of chronic lymphocytic leukaemia F Gaiti, R Chaligne, H Gu, RM Brand, S Kothen-Hill, RC Schulman, ... Nature 569 (7757), 576-580, 2019 | 248 | 2019 |
| DNA methylation disruption reshapes the hematopoietic differentiation landscape F Izzo, SC Lee, A Poran, R Chaligne, F Gaiti, B Gross, RR Murali, ... Nature genetics 52 (4), 378-387, 2020 | 231 | 2020 |
| Transcriptomic characterization of SF3B1 mutation reveals its pleiotropic effects in chronic lymphocytic leukemia L Wang, AN Brooks, J Fan, Y Wan, R Gambe, S Li, S Hergert, S Yin, ... Cancer cell 30 (5), 750-763, 2016 | 228 | 2016 |
| Clonal evolution in hematological malignancies and therapeutic implications DA Landau, SL Carter, G Getz, CJ Wu Leukemia 28 (1), 34-43, 2014 | 227 | 2014 |
| Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand? P Cacoub, A Delluc, D Saadoun, DA Landau, D Sene Annals of the Rheumatic Diseases 67 (3), 283-287, 2008 | 217 | 2008 |
| Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation D Saadoun, DA Landau, LH Calabrese, PP Cacoub Rheumatology 46 (8), 1234-1242, 2007 | 212 | 2007 |
| The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy DA Landau, C Sun, D Rosebrock, SEM Herman, J Fein, M Sivina, ... Nature communications 8 (1), 2185, 2017 | 195 | 2017 |
| Chromosomal instability as a driver of tumor heterogeneity and evolution SF Bakhoum, DA Landau Cold Spring Harbor perspectives in medicine 7 (6), a029611, 2017 | 185 | 2017 |
| Epigenetic encoding, heritability and plasticity of glioma transcriptional cell states R Chaligne, F Gaiti, D Silverbush, JS Schiffman, HR Weisman, L Kluegel, ... Nature genetics 53 (10), 1469-1479, 2021 | 182 | 2021 |
Gad GetzMassachusetts General Hospital and Broad Institute of Harvard and MITVerified email at broadinstitute.org